May 20 |
Palatin Technologies (PTN) Upgraded to Buy: What Does It Mean for the Stock?
|
May 16 |
Palatin Technologies Inc (PTN) (Q3 2024) Earnings Call Transcript Highlights: Navigating ...
|
May 16 |
Q3 2024 Palatin Technologies Inc Earnings Call
|
May 15 |
Palatin Technologies, Inc. (PTN) Q3 2024 Earnings Call Transcript
|
May 15 |
Palatin Tech GAAP EPS of -$0.53 misses by $0.03
|
May 15 |
Palatin Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
|
May 14 |
Palatin Tech Q3 2024 Earnings Preview
|
May 9 |
Palatin to Report Third Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on May 15, 2024
|
May 2 |
Palatin gets FDA OK to test weight loss therapy with Eli Lilly’s tirzepatide
|
May 2 |
Palatin Announces FDA Clearance of IND Application for the Co-Administration of Bremelanotide with Tirzepatide (GLP-1) for the Treatment of Obesity
|